Background. The purpose of the present study was to test the effects of lidocaine on the relation between the defibrillation threshold and the upper limit of vulnerability.
ful defibrillation, a shock must reach the upper limit of vulnerability so that VF cannot be reinitiated. This hypothesis is supported by the significant correlation between the defibrillation threshold and the upper limit of vulnerability.2,56 One study2 tested the correlation between the upper limit of vulnerability and the defibrillation threshold when two different defibrillation patch electrode configurations were used. The results showed that when the defibrillation threshold increased, so did the upper limit of vulnerability. Significant correlations between the two values were found for both defibrillation electrode configurations. However, because electrical induction and termination of VF depend on not only the shock field strength distribution78 but also the electrophysiological state of the myocardium,S13,4,9 it is important to test this correlation when the electrophysiological state is perturbed but the field strength remains constant. Lidocaine was recently shown to significantly increase the defibrillation threshold10"l and is therefore an ideal agent with which to perturb the electrophysiological state of the myocardium and to test the correlation between the upper limit of vulnerability and the defibrillation threshold. The purpose of the present study was to compare the upper limit of vulnerability and the defibrillation threshold before and during lidocaine administration without changing the location of the defibrillation patch electrodes. The upper limit of vulnerability hypothesis of defibrillation will be supported if lidocaine infusion significantly increases both the upper limit of vulnerability and the defibrillation threshold, and there is a significant correlation between the two values both at baseline and during the administration of lidocaine. However, if the results show that lidocaine alters the upper limit of vulnerability and defibrillation threshold to a different degree, then other mechanisms have to be considered to explain these findings.
Methods

Surgical Preparation
Adult Delayed up-down algorithm. The delayed up-down algorithmA4 was used to determine the shock strength associated with a 50% probability of reaching the upper limit of vulnerability (ULVso) and the shock strength associated with a 50% probability of successful defibrillation (DFT50). The up-down algorithm began by giving the first shock at a strength estimated to yield a 50% successful defibrillation. If this initial shock was unsuccessful, the shock strength was increased by a certain a value for the next shock. If a shock was successful, the shock strength was decreased by the same S value for the next shock. This process was continued until four shocks were delivered and one shock strength was projected but not delivered. The five shock strengths were then averaged for the threshold estimate.
This up-down algorithm is accurate only when the a priori estimates are good. The accuracy is significantly reduced for poor a priori estimates of the DFT5o. This problem can be overcome by the delayed four-episode, up-down algorithm. This algorithm does not start counting the four required observations until the first reversal in response. With this procedure, the accuracy of determining the DFT50 is greatly improved because it does not depend on the accuracy of an a priori estimate of the initial shock strength.
VF induction and ULV50 determination. The ULV50 was determined by the delayed up-down algorithm. The ventricles were paced at a 300-msec cycle length for 11 beats. The intervals between the last S, pacing artifact and the onset, peak, and end of the T waves on ECG lead II were determined by the mapping system. To induce VF and test the ULV5,, a shock with a strength of 300 V was given at the onset of the T wave. The S1S2 intervals were then progressively increased at 10-msec increments until a total of 15 shocks were given or VF was induced. With this method, the entire T wave was scanned. All shocks that did not induce VF were separated by 1 minute. Depending on whether VF was induced, subsequent shocks were given with a shock strength of 50 V higher or lower, respectively, than the previous shock energy until the opposite result was observed. The shock strength immediately preceding the opposite result was the first data point. The shock strength associated with the opposite result was the second data point. The up-down algorithm was then continued until a total of four data points were obtained and one was predicted.14 The ULV50 was determined by averaging the five shock strengths. The shocks given before the first data point were excluded from analysis.
VF termination and DFT50 determination. VF was induced as part of the upper limit of vulnerability testing described above. If the determination of DFTso had not been completed at the end of the ULV50 testing, additional episodes of fibrillation-defibrillation were performed. The VF during these episodes was induced by giving a 100-V shock during the vulnerable period. Once VF was induced, the DFTso was determined with 6-msec monophasic shocks using the delayed up-down algorithm. The first defibrillation shock was 300 V for each dog studied. In subsequent episodes, the shock energy was increased by 50 V after failures or decreased by 50 V after successes until the opposite results were observed. The shock strength immediately preceding fibrillation waveform was used throughout the study. the opposite result was the first data point. The shock strength associated with the opposite result was the second data point. The up-down algorithm was then continued until a total of four data points were obtained and one was predicted.14 The DFT50 was determined by averaging the five shock strengths. The shocks given before the first data point were excluded from analysis. All fibrillationdefibrillation episodes were separated by at least 5 minutes. Salvage shocks were given immediately after an unsuccessful defibrillation shock. The shock strength of the salvage shock was not included in the data analysis. Four dogs were used in this protocol. After baseline testing of the ULV5o and the DFT50, normal saline was administered (10-ml load over 10 minutes followed by 1 ml/min maintenance). The ULV50 and the DFT50 were redetermined during stable maintenance infusion 1 hour later. The DFT50 was then determined for the third time when the VF was induced with rapid ventricular pacing.
Data Analysis
The QRS widths and the QT intervals of ECG lead II were measured during sinus rhythm. The QT, was calculated by dividing the QT interval by the square root of the preceding RR interval (seconds). The intervals between the stimulus and the onset, peak, and end of the T wave of the last S, beat were also measured. These data were compared with the SIS2 interval to determine where on the T wave a shock was given. All statistical analyses were performed with SYSTAT.15 The Pearson correlation coefficient analysis, linear regression analysis, and Newman-Keuls test were used to compare the ULV50 and the DFT50 before and during lidocaine infusion. The t tests and Pearson correlation coefficient analyses were also used to compare the QRS widths, QT, intervals, and increments of the ULV50 and the DFT50 before and during lidocaine infusion. A value of pc0.05 was considered significant.
Results
Protocol 1
The mean+SD body weight of the seven dogs studied was 21+3 kg, and the mean±SD heart weight was 162±25 g. The serum lidocaine concentration was 18±13 ,gg/ml 1 hour after the loading dose and 15±4
,ug/ml at the end of the study (p=NS). (Figure 1 ).
The increments of the ULV50 and the DFT50 were highly correlated (Figure 2) which VF cannot be induced even if the stimulus were given during the vulnerable period of the cardiac cycle. A similar phenomenon has also been observed in the atrium.17 Subsequently, investigators demonstrated that the upper limit of vulnerability correlated well with the defibrillation threshold.25'6 By changing the location of the anodal defibrillation patch electrode from the right to the left atrium, with the same cathodal electrode on the left ventricular apex, alterations of the electrical field distribution resulted in the increase of not only the defibrillation threshold but also the upper limit of vulnerability as well.2 The correlation between the two values was significant for either electrode combination. Furthermore, more recent studies'8 showed that like the defibrillation threshold,19 the upper limit of vulnerability is a probability function, and the probability curves of these two tests in the same animal parallel each other. In the present study, we demonstrated that the upper limit of vulnerability and the defibrillation threshold can both be increased by the administration of lidocaine without changing the location of the defibrillation patch electrodes. The two values were highly correlated, both at baseline and during the lidocaine infusion. The increments of these two values were also highly correlated. In contrast, normal saline infusion did not alter either the ULV50 or the DFT50. These data showed that with the perturbation of either the field strength distribution2 or the electrophysiological state of the myocardium, the defibrillation threshold and the upper limit of vulnerability remain closely correlated.
Although this close correlation supports the upper limit of vulnerability hypothesis of defibrillation,1-4 a greater increase of the upper limit of vulnerability than of the defibrillation threshold with the administration of lidocaine indicates that other factors may also need to be considered to explain these results. It is well known that the sodium channel-blocking effect of lidocaine is dependent on the heart rate (use dependence) and the transmembrane potential.20-23 Ventricular fibrillation is associated with a cycle length of approximately 100 msec1 and transmembrane action potentials of extremely short duration and low amplitude. 24, 25 Although the short cycle length during VF may facilitate sodium channel block,20-23 the brief duration of the action potential is unfavorable for the blocking action of lidocaine.2627 Because of the differences in cycle lengths and the transmembrane action potentials between the paced rhythm and VF, the sodium channel-blocking effects of lidocaine could also differ. This difference may account for the discrepancies between the increments of the upper limit of vulnerability and the defibrillation threshold during lidocaine infusion.
The second possibility is the different magnitude of action potential and refractory period extension produced by shocks during VF and during paced rhythm. The upper limit of vulnerability hypothesis proposed that after an unsuccessful defibrillation shock, new activation wave fronts arise as a result of a complex interaction between the shock's electric field and tissue refractoriness. 4 Two results of such an interaction are the time-and energy-dependent action potential28'29 and refractory period30-32 extension. The magnitude of the action potential and the refractory period extension may be important in determining vulnerability and defibrillation. Because of the faster excitation rate during VF, the action potential was much shorter during VF than it was during paced rhythm. It is highly probable that the extents of the action potential and the refractory period extension after a shock during VF differ significantly from that found during paced rhythm, even though the strength of the shock is the same. The effects of such a difference may be aggravated by lidocaine and account for the differences between the ULV50 and the DFT50 during lidocaine infusion.
The third possible explanation is that the upper limit of vulnerability hypothesis is incorrect. Shibata We33 previously demonstrated that the upper limit of vulnerability determined at the midupslope of the T wave can be used to accurately predict the defibrillation threshold. In contrast, the upper limit of vulnerability determined at the peak and the middownslope of the T wave had a poorer correlation with, and was significantly lower than, the defibrillation threshold. We concluded that the defibrillation threshold could be estimated by shocks given only at the midupslope of the T wave. In the present study, we scanned the T wave starting with short S1S2 intervals, and then progressively increased the SIS2 coupling interval if the previous shock failed to induce VF. We found that both before and during lidocaine infusion, the shock that induced VF also occurred at the upslope of the T wave. Further studies will be needed to determine whether the midupslope is also the best time to test the upper limit of vulnerability during lidocaine infusion.
Accuracy of DFT50 Determination
There is no consensus on which method best estimates the defibrillation efficacy. Two methods have been used the most. The first is the "defibrillation threshold" method,34 and the second is the "dose-response curve" method.'9 Jones et a135 recently compared these two methods using animal experiments. To determine the defibrillation threshold, they used an iterative incrementdecrement protocol similar to the delayed up-down methods14 used in the present study. The results were compared with the DFT50 determined by the doseresponse curve method. The results showed that there was no statistical difference between the DIFI50 as estimated by either method. These experimental results are compatible with the results obtained by mathematical modeling study14 and showed that the DFT50 can be accurately estimated with an up-down algorithm without constructing the entire dose-response curve of defibrillation. Based on the results of these studies,'4 '35 we believe that the methods used in the present study produce accurate estimates of the DFT50.
